SG11202111365QA - Controlling intersample analyte variability in complex biological matrices - Google Patents

Controlling intersample analyte variability in complex biological matrices

Info

Publication number
SG11202111365QA
SG11202111365QA SG11202111365QA SG11202111365QA SG11202111365QA SG 11202111365Q A SG11202111365Q A SG 11202111365QA SG 11202111365Q A SG11202111365Q A SG 11202111365QA SG 11202111365Q A SG11202111365Q A SG 11202111365QA SG 11202111365Q A SG11202111365Q A SG 11202111365QA
Authority
SG
Singapore
Prior art keywords
intersample
controlling
complex biological
biological matrices
analyte variability
Prior art date
Application number
SG11202111365QA
Other languages
English (en)
Inventor
Thomas Hraha
Original Assignee
Somalogic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somalogic Inc filed Critical Somalogic Inc
Publication of SG11202111365QA publication Critical patent/SG11202111365QA/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/20—Identification of molecular entities, parts thereof or of chemical compositions

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Computing Systems (AREA)
  • Theoretical Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SG11202111365QA 2019-05-17 2020-05-15 Controlling intersample analyte variability in complex biological matrices SG11202111365QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962849212P 2019-05-17 2019-05-17
PCT/US2020/033033 WO2020236544A1 (en) 2019-05-17 2020-05-15 Controlling intersample analyte variability in complex biological matrices

Publications (1)

Publication Number Publication Date
SG11202111365QA true SG11202111365QA (en) 2021-11-29

Family

ID=71016636

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202111365QA SG11202111365QA (en) 2019-05-17 2020-05-15 Controlling intersample analyte variability in complex biological matrices

Country Status (11)

Country Link
US (1) US20220260585A1 (enrdf_load_stackoverflow)
EP (1) EP3969900A1 (enrdf_load_stackoverflow)
JP (1) JP2022532212A (enrdf_load_stackoverflow)
KR (1) KR20220009948A (enrdf_load_stackoverflow)
CN (1) CN113826170B (enrdf_load_stackoverflow)
AU (1) AU2020278570A1 (enrdf_load_stackoverflow)
BR (1) BR112021022532A8 (enrdf_load_stackoverflow)
CA (1) CA3140053A1 (enrdf_load_stackoverflow)
IL (1) IL288014A (enrdf_load_stackoverflow)
SG (1) SG11202111365QA (enrdf_load_stackoverflow)
WO (1) WO2020236544A1 (enrdf_load_stackoverflow)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202116626D0 (en) * 2021-11-18 2022-01-05 Fluidic Analytics Ltd Improvements in or relating to a method of analysing a component in a sample
CN117497037B (zh) * 2023-11-17 2024-08-16 上海倍谙基生物科技有限公司 一种基于广义线性模型的培养基组分敏感性分析方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69133513T2 (de) 1990-06-11 2006-09-21 Gilead Sciences, Inc., Foster City Verfahren zur Verwendung von Nukleinsäureliganden
US5719273A (en) 1993-06-14 1998-02-17 Nexstar Pharmaceuticals, Inc. Palladium catalyzed nucleoside modifications methods using nucleophiles and carbon monoxide
US5945527A (en) 1996-05-30 1999-08-31 Nexstar Pharmaceuticals, Inc. Palladium catalyzed nucleoside modification methods using nucleophiles and carbon monoxide
US6242246B1 (en) 1997-12-15 2001-06-05 Somalogic, Inc. Nucleic acid ligand diagnostic Biochip
EP1502117B1 (en) * 2002-04-23 2011-08-10 Home Access Health Corporation Quantitative analysis of a biological sample of unknown quantity
US7373256B2 (en) * 2005-04-19 2008-05-13 Nicholson Jeremy K Method for the identification of molecules and biomarkers using chemical, biochemical and biological data
US7855054B2 (en) 2007-01-16 2010-12-21 Somalogic, Inc. Multiplexed analyses of test samples
US7947447B2 (en) 2007-01-16 2011-05-24 Somalogic, Inc. Method for generating aptamers with improved off-rates
EP2076613B1 (en) * 2007-07-17 2016-09-07 Somalogic, Inc. Analyses of test samples
US8260556B2 (en) * 2008-08-21 2012-09-04 Bio-Rad Laboratories, Inc. Calibration surface method for determination on of analyte ratios
WO2011017436A2 (en) * 2009-08-04 2011-02-10 The Johns Hopkins University A high precision quantitative assay composition and methods of use therefor
KR101842269B1 (ko) 2010-04-12 2018-03-26 소마로직, 인크. 5-위치 변경된 피리미딘 및 그것의 용도
EP2571997A2 (en) * 2010-05-21 2013-03-27 Ohmx Corporation Enzymatic activity of psa as diagnostic marker for prostate cancer
KR101909764B1 (ko) * 2011-01-21 2018-12-10 테라노스, 인코포레이티드 샘플 사용 최대화를 위한 시스템 및 방법
CA2939999C (en) * 2014-02-18 2023-03-21 Somalogic, Inc. Compositions and methods for detecting microorganisms

Also Published As

Publication number Publication date
BR112021022532A2 (enrdf_load_stackoverflow) 2021-12-28
CN113826170B (zh) 2024-12-27
CN113826170A (zh) 2021-12-21
CA3140053A1 (en) 2020-11-26
KR20220009948A (ko) 2022-01-25
AU2020278570A1 (en) 2022-01-06
EP3969900A1 (en) 2022-03-23
WO2020236544A1 (en) 2020-11-26
IL288014A (en) 2022-01-01
JP2022532212A (ja) 2022-07-13
US20220260585A1 (en) 2022-08-18
BR112021022532A8 (pt) 2022-10-11

Similar Documents

Publication Publication Date Title
SG11202103192RA (en) Il-12 heterodimeric fc-fusion proteins
IL286495A (en) Reducing inter-sample analysis variability in complex biological matrices
IL287318A (en) Materials and methods for the production of proteins
EP3735481A4 (en) METHODS OF MANUFACTURING A HIGH RESOLUTION DNA CHIP AND USING THE SAME IN SEQUENCING
EP3740231A4 (en) PROGRAMMABLE PROTEIN CIRCUITS IN LIVING CELLS
IL278022A (en) A microfluidic method for single cell analysis
EP3674419A4 (en) PROBE AND APPLICANT METHOD FOR ENRICHING A TARGET REGION IN HIGH-RATE SEQUENCING
IL288014A (en) Controlling inter-sample test substance variability in complex biological matrices
SG11202010543QA (en) Yeast proteins
GB201907242D0 (en) Dna methods etc ii
IL268330A (en) Methods for determining interaction between biological cells
SG11202006140TA (en) Process for providing pegylated protein composition
IL287077A (en) Methods and systems for scanning using a microcapillary array
GB201913908D0 (en) Improvements in interaction analysis
IL281796A (en) Quantification of antibody in biological samples
HK40069493A (en) Controlling intersample analyte variability in complex biological matrices
HK40061957B (en) Controlling intersample analyte variability in complex biological matrices
HK40066203A (en) Reducing intersample analyte variability in complex biological matrices
GB201817485D0 (en) Protein tablets
GB201710524D0 (en) Controlling intersample analyte variability in complex biological matrices
GB201820395D0 (en) Assay Analysis
IL286419A (en) A cell line containing a new form of selection marker and using them to make proteins
SG11202011592SA (en) Hsp70 protein levels in pbmc samples as biomarker for disease
DK3615689T3 (en) Analytical methods and arrays for use in the same
SG11202005990RA (en) Process for providing pegylated protein composition